Phage Immunoprecipitation Sequencing of Autoantigens in Autoimmune Retinopathy

REFERENCES

• Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina. 2014;34:827–845.
   PubMed Web of Science ®Google Scholar
• Forooghian F. The uncertainty regarding antiretinal antibodies. JAMA Ophthalmol. 2015;133:744–745.
   PubMed Web of Science ®Google Scholar
• Faez S, Loewenstein J, Sobrin L. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol. 2013;131:113–115.
   PubMed Web of Science ®Google Scholar
• Forooghian F, Macdonald IM, Heckenlively JR, et al. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2008;146:489–495.
   PubMed Web of Science ®Google Scholar
• Larman HB, Zhao Z, Laserson U, et al. Autoantigen discovery with a synthetic human peptidome. Nat Biotechnol. 2011;29:535–541.
   PubMed Web of Science ®Google Scholar
• Larman HB, Laserson U, Querol L, et al. PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis. J Autoimmun. 2013;43:1–9.
   PubMed Web of Science ®Google Scholar
• Fox AR, Gordon LK, Heckenlively JR, et al. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified delphi approach. Am J Ophthalmol. 2016;168:183–190.
   PubMed Web of Science ®Google Scholar
• Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004;4:5.
   PubMedGoogle Scholar
• Moreira EF, Jaworski CJ, Rodriguez IR. Cloning of a novel member of the reticulon gene family (RTN3): gene structure and chromosomal localization to 11q13. Genomics. 1999;58:73–81.
   PubMed Web of Science ®Google Scholar
• Joseph CG, Darrah E, Shah AA, et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science. 2014;343:152–157.
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Lee HW, Kim HR, et al. Ubiquitin-specific protease 4 controls metastatic potential through beta-catenin stabilization in brain metastatic lung adenocarcinoma. Sci Rep. 2016;6:21596.
   PubMed Web of Science ®Google Scholar
• Cao WH, Liu XP, Meng SL, et al. USP4 promotes invasion of breast cancer cells via Relaxin/TGF-beta1/Smad2/MMP-9 signal. Eur Rev Med Pharmacol Sci. 2016;20:1115–1122.
   PubMed Web of Science ®Google Scholar
• Wen L, Liang C, Chen E, et al. Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent. Sci Rep. 2016;6:23269.
   PubMed Web of Science ®Google Scholar
• Brueckner LM, Hess EM, Schwab M, et al. Instability at the FRA8I common fragile site disrupts the genomic integrity of the KIAA0146, CEBPD and PRKDC genes in colorectal cancer. Cancer Lett. 2013;336:85–95.
   PubMed Web of Science ®Google Scholar
• Wan L, Han J, Liu T, et al. Scaffolding protein SPIDR/KIAA0146 connects the Bloom syndrome helicase with homologous recombination repair. Proc Natl Acad Sci U S A. 2013;110:10646–10651.
   PubMed Web of Science ®Google Scholar
• Liu J, Shen L, Yang L, et al. High expression of beta3GnT8 is associated with the metastatic potential of human glioma. Int J Mol Med. 2014;33:1459–1468.
   PubMed Web of Science ®Google Scholar
• Shen L, Yu M, Xu X, et al. Knockdown of beta3GnT8 reverses 5-fluorouracil resistance in human colorectal cancer cells via inhibition the biosynthesis of polylactosamine-type N-glycans. Int J Oncol. 2014;45:2560–2568.
   PubMed Web of Science ®Google Scholar
• Liu Z, Shen L, Xu L, et al. Down-regulation of beta-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. Mol Med Rep. 2011;4:497–503.
   PubMed Web of Science ®Google Scholar
• Zhang M, Luo SC. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance. Genet Mol Res. 2016;15(1).
   Web of Science ®Google Scholar
• Huang X, Yang H, Zhou Y, et al. Overexpression of human reticulon 3 (hRTN3) in astrocytoma. Clin Neuropathol. 2004;23:1–7.
   PubMed Web of Science ®Google Scholar
• Parmenter TJ, Kleinschmidt M, Kinross KM, et al. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov. 2014;4:423–433.
   PubMed Web of Science ®Google Scholar
• Oikawa K, Ohbayashi T, Kiyono T, et al. Expression of a novel human gene, human wings apart-like (hWAPL), is associated with cervical carcinogenesis and tumor progression. Cancer Res. 2004;64:3545–3549.
   PubMed Web of Science ®Google Scholar
• Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60:6116–6133.
   PubMed Web of Science ®Google Scholar
• Tanackovic G, Ransijn A, Ayuso C, et al. A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa. Am J Hum Genet. 2011;88:643–649.
   PubMed Web of Science ®Google Scholar
• Wang X, Teng L, Li A, et al. TRPC6 channel protects retinal ganglion cells in a rat model of retinal ischemia/reperfusion-induced cell death. Invest Ophthalmol Vis Sci. 2010;51:5751–5758.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331:1565–1570.
   PubMed Web of Science ®Google Scholar
• Zhang X, Berger FG, Yang J, et al. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. Embo J. 2011;30:2177–2189.
   PubMed Web of Science ®Google Scholar
• Robinson WH, Steinman L. Human peptidome display. Nat Biotechnol. 2011;29:500–502.
   PubMed Web of Science ®Google Scholar